Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Mauritania
Mauritania: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage was 85.0% in 2024. ▲ Rising
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Mauritania, 2013–2024
Source: WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data. Measured in %.
Analysis
Mauritania recorded 85.0% for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in 2024.
The figure is down 5.6% on the previous year and up 19.7% over ten years.
Over the whole period, pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Mauritania peaked at 90.0% in 2023 and was at its lowest, 1.0%, in 2013.
That places Mauritania 88th out of 146 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently rising across the 12 years of available data.
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Mauritania, year by year
| Year | % | Change |
|---|---|---|
| 2013 | 1.0% | — |
| 2014 | 71.0% | +7000.0% |
| 2015 | 71.0% | +0.0% |
| 2016 | 71.0% | +0.0% |
| 2017 | 72.0% | +1.4% |
| 2018 | 72.0% | +0.0% |
| 2019 | 76.0% | +5.6% |
| 2020 | 82.0% | +7.9% |
| 2021 | 77.0% | -6.1% |
| 2022 | 85.0% | +10.4% |
| 2023 | 90.0% | +5.9% |
| 2024 | 85.0% | -5.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 62.0% | 1.0% | 76.0% | 7 |
| 2020s | 83.8% | 77.0% | 90.0% | 5 |
Countries ranked near Mauritania
More health data for Mauritania
- Un projection of annual infant deaths, annual growth rate -0.8878 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.19 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 653 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,563 deaths (2100)
- Population ages 0-14, female, annual growth rate 2.03 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.2093 units per person (2025)
- Population ages 0-14, male, annual growth rate 2.03 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.2146 units per person (2025)
Frequently asked questions
- What is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Mauritania?
- Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Mauritania was 85.0% in 2024, according to WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data.
- What is the highest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Mauritania?
- The highest recorded value was 90.0% in 2023.
- What is the lowest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Mauritania?
- The lowest recorded value was 1.0% in 2013.
- How does Mauritania rank for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Mauritania ranks 88th out of 146 countries with data for 2024.
- Is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage rising or falling in Mauritania?
- Over the last ten years it is up 19.7%. The long-run trend across the full record is rising.
- Where does this Mauritania data come from?
- The figures come from WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as part of Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 12 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.